Progress of perfluorobutane in the diagnosis and treatment of hepatocellular carcinoma
10.3760/cma.j.cn113884-20250227-00064
- VernacularTitle:全氟丁烷在肝细胞癌诊断和治疗中的应用进展
- Author:
Zeyin ZHAO
1
;
Liping LIU
1
Author Information
1. 山西医科大学第一医院超声介入科，太原 030001
- Publication Type:Journal Article
- Keywords:
Carcinoma, hepatocellular;
Contrast-enhanced ultrasound;
Perfluorobutane microbubble;
Diagnosis;
Treatment
- From:
Chinese Journal of Hepatobiliary Surgery
2025;31(4):313-317
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma (HCC) is a common malignancy with poor prognosis, highlighting the need for precise and effective diagnosis and treatment. Perfluorobutane has shown unique advantages and potential in the diagnosis and treatment of HCC. This review focuses on perfluorobutane, summarizing its fundamental properties and recent advances in HCC diagnosis and management. In addition, it discusses the current challenges associated with the application of perfluorobutane and explores its future research, providing valuable insights into the management of HCC.
